To further democratise derivatives trading and enrich the available content, Euronext launched an educational programme for ...

February at 07:00 am CET. The quarterly report and the presentation materials will be available on the in Oslo. A light breakfast will be served from 08:00. The presentation will be held in Norwegian ...

Scatec's corporate maturity profile and enhance its financial flexibility. Scatec remains committed to continue deleveraging on corporate level and use 75% of divestment proceeds to repay corporate ...

outstanding in the bond issue after this transaction is NOK 1,800,000,000. The transaction was arranged by Nordea. Entra is a leading owner, manager and developer of office properties in Norway. Entra ...

of net profit after tax in 2024 was NOK 146 (-21) million. Fremtind Holding Group, owned 51,44 % by SpareBank 1 Gruppen AS, reported a pre-tax profit of NOK 1 170 (794) million in the 4th quarter and ...

Rana Gruber ASA will release its fourth-quarter results for 2024 on Thursday, February 13, at 7:00 a.m. CET. The results will be presented in a webcast with CEO Gunnar Moe and CFO Erlend Høyen at 8:00 ...

2024 at or around 20:00 CET on Wednesday 12 February 2025. The report and presentation material will be made available on newsweb.oslobors.no and wilhelmsen.com. A live webcast presentation followed ...

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today reports its IFRS unaudited estimated financial results for the fourth quarter 2024 and full year ended December 31, 2024. The Group’s ...

The board of directors of Nordic Unmanned ASA (the "Company") has today, 3. February 2025, resolved to file a petition for bankruptcy at Sør-Rogaland tingrett (Sør-Rogaland District Court). The ...

developing ContextVision's new product line within data quality ultrasound.

Teleperformance (TP) (Paris:TEP), a global leader in digital business services, today announced that it has completed the acquisition of ‘ZP Better Together’, a fast-growing leader in providing ...

Median Technologies (FR0011049824, ALMDT, PEA/SME scheme eligible), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer ...